News | July 02, 2024
Abbott and YRGCARE inaugurate new outreach centers in India
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Imfinzi also recommended for patients with mismatch repair deficient disease
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy
Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research (AACR) annual meeting on Monday, April 8 and highlighted as part of the official meeting press program
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
